Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease

This study has been terminated.
(Low enrollment)
Hope Pharmaceuticals
Information provided by (Responsible Party):
Thomas Coates, Children's Hospital Los Angeles Identifier:
First received: December 15, 2009
Last updated: July 27, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)